1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1nareshArray
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Comparison of ultra-small particle iron oxide (USPIO) versus gadolinium MRI to detect multiple sclerosis brain lesions with macrophage infiltration and/or blood–brain barrier permeability
No. of Patients Out of 10 No. of MRI Brain Lesions (n = 57)
USPIO total 9 33
Gadolinium total 7 55
USPIO and gadolinium 7 31
USPIO only 2 2
Gadolinium only 7 24
	No. of Patients Out of 10	No. of MRI Brain Lesions (n = 57)
USPIO total	9	33
Gadolinium total	7	55
USPIO and gadolinium	7	31
USPIO only	2	2
Gadolinium only	7	24